Biochemistry & Molecular Biology43

Pub YearTitleAJOU Author(s)
-A composition for anti-cancer adjuvant comprising a RIP3 expression inducing agent or activator김유선
2016Anti-cancer supplement agent comprising flunarizine for glioma김인영, 최경숙
2015Anti-cancer supplement agent comprising polyether antibiotics for gliomas최경숙
2017Anticancer supplement composition comprising RIP3 activator구기방, 김유선
2018Anticancer supplement composition comprising RIP3 activator, Method for screening anticancer supplement agents inducing RIP3 expression for enhancing sensitivity to anticancer agents and method for monitoring sensitivity to anticancer agents구기방, 김유선
2018Biomarker composition for diagnosing cancer with mitochondrial dysfunction and method for diagnosing cancer using the same marker우현구, 윤계순, 이영경
2017Biomarker composition for diagnosing cancer with mitochondrial dysfunction comprising NUPR1 and method for diagnosing cancer using the same marker우현구, 윤계순, 이영경
-Biomarker composition for diagnosing cell senescence comprising UHRF1 and DNMT1변해옥, 윤계순, 이영경
-BIOMARKER FOR PREEDICTING FEMALE SPECIFIC LIVER CANCER MALIGNANCY AND USE THEREOF김유선
-Biomarkers for diagnosing cancer and method for isolating cancer cell using the same김유선
2022Biomarkers for diagnosing osteoarthritis김유선, 양시영
2020CANCER CELL LINE FOR EVALUATING PARAPTOSIS, SCREENING METHOD FOR THE PARAPTOSIS INDUCERS AND SCREENING METHOD FOR SENSITIZERS OF PROTEASOME INHIBITORS USING THE SAME최경숙
-Composition and kit for cancer cell, and method for separating cancer cell using the same김유선
2018Composition comprising expression regulator for preventing or treating non-alcoholic fatty liver유민숙, 임인경, 최정아
-Composition containing B-cell lymphoma 2 inhibitor for anti-aging and whitening강희영, 박태준
-Composition for preventing or treating osteoarthritis comprising Neratinib김유선, 양시영
-Composition for preventing or treating osteoarthritis comprising Selumetinib김유선, 양시영
2016Composition for preventing or treating tumor comprising proteasome inhibitor and dihydropyridine compound김인영, 최경숙
2017Composition for regulating cutaneous pigmentation derived from endothelial cells or secretory factors from endothelial cells and method for screening skin whitening agents강희영, 김미선, 박지윤, 박태준
2018Composition for regulating cutaneous pigmentation or skin whitening comprising SDF1강희영, 김미선, 박태준
2018Composition for skin whitening comprising clusterin강희영, 김미선, 박태준
2016Composition for treating pigmentary disorder or whitening skin through pleiotrophin modulation강희영, 박태준
2022Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor김장희, 박태준, 최용원
-Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor김장희, 박태준, 최용원
-Cosmetic Composition for Prevention of Skin Senescence김홍석, 유민숙, 임인경, 최옥란
2019Increasing red muscle mass through TIS21 gene expression유민숙, 임인경
2015Kit and method for diagnosis of cell senescence김유미, 변해옥, 우현구, 윤계순
2017MARCH5 K40/54R mutant protein maintaining MARCH5 activity and increasing protein stability김송희, 박용예, 유영석, 조혜성
2017Method for screening anticancer supplement agents inducing RIP3 expression for enhancing sensitivity to anticancer agents and method for monitoring sensitivity to anticancer agents구기방, 김유선
2015Method for screening modulator of RIG-I mediated immune response via stabilization of MARCH5 expression김송희, 박용예, 유영석, 조혜성
2015Method for screening therapeutic agent of liver cancer by inducing HBx degradation via stabilization of MARCH5 expression박용예, 조혜성
-Method of obtaining information for identifying a tumor cell processed with epithelial-mesenchymal transition in a sample, method for identifying a tumor cell processed with epithelial-mesenchymal transition in a sample, method for diagnosing a subject suffering a tumor and composition or kit for identifying a tumor cell processed with epithelial-mesenchymal transition in a sample김유선
2006Micro Pump백운기
-Patch-type skin moisture level sensor이진구
2016Pharmaceutical composition comprising RIP3-MLKL pathway blocker for preventing or treating of skin cell necrosis disease구기방, 김유선
-Pharmaceutical composition for preventing or treating bladder cancer comprising inducer or activator of BTG2 and screening method thereof임인경
2017Pharmaceutical composition for preventing or treating miRNA-34a related diseases comprising inducer or activator of TIS21 and screening method thereof유민숙, 임인경
2014Pharmaceutical composition for treating or preventing cancer disease comprising proteasome inhibitor and loperamide김인영, 최경숙
-Pharmaceutical composition of TIS21/BTG2 induser or activator for treatment or prevention of human diseases related with Diaphanous-related formins임인경, 최정아
2015Pharmaceutical composition with antiviral activity comprising inhibitor of MARCH5 expression and screening method thereof박용예, 유영석, 조혜성
2018Recombinant BTG2 protein and production method thereof유민숙, 임인경
2020Screening method for skin whitening agents using SDF1 promoter region강희영, 박태준
2017Screening Method of therapeutic agents for cancer with mitochondrial dysfunction by regulation of Claudin-1 expression윤계순, 이영경
1

Browse